Statement Of Cash Flows [Abstract]

Gentian Diagnostics ASA - Filing #5597205

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
13 457 NOK
15 458 NOK
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
- NOK
390,000 NOK
Purchase of property, plant and equipment, classified as investing activities
1 377 NOK
955,000 NOK
Purchase of intangible assets, classified as investing activities
9 573 NOK
3 532 NOK
Cash flows from (used in) investing activities
10 950 NOK
4 877 NOK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
4 950 NOK
4 598 NOK
Cash flows from (used in) financing activities
4 950 NOK
4 598 NOK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
2 442 NOK
5 982 NOK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
462,000 NOK
61,000 NOK
Cash and cash equivalents
84 738 NOK
87 642 NOK
81 599 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.